Page last updated: 2024-08-23

simvastatin and Proteinuria

simvastatin has been researched along with Proteinuria in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (28.57)18.2507
2000's11 (52.38)29.6817
2010's4 (19.05)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Fijter, JW; Dekker, FW; Dekkers, OM; Esmeijer, K; Hoogeveen, EK1
Koskinen, PK; Palin, NK; Rintala, JM; Savikko, J1
Li, Q; Sun, S; Wang, C; Xu, Y; Zhen, J1
Chan, AO; Chan, GP; Chan, YH; Chau, KF; Cheung, CY; Lau, GT; Lee, KC; Li, CS; Shek, CC1
Akbaş, H; Akkaya, B; Akman, S; Baysal, YE; Guven, AG; Kalay, S; Koyun, M1
Biesenbach, P; Gremmel, T; Hörl, WH; Kain, R; Säemann, MD1
Abud-Mendoza, C; Baranda, L; Cruz-Rizo, J; Cuevas-Orta, E; de la Fuente, H; González-Amaro, R1
Cremonesi, B; Gelosa, P; Gianazza, E; Gianella, A; Guerrini, U; Nobili, E; Paoletti, R; Sironi, L; Tremoli, E1
Hu, Y; Lin, F; Shen, H; Zhou, J; Zhu, B1
Christensen, M; Greco, A; Lipschutz, JH; Madaio, MP; Snyder, RW; Su, AW1
Deray, G; Isnard-Bagnis, C; Karie, S; Launay-Vacher, V1
Abbate, M; Banfi, C; Bellosta, S; Brioschi, M; Canavesi, M; Gelosa, P; Gianella, A; Guerrini, U; Mussoni, L; Nobili, E; Remuzzi, G; Rottoli, D; Sironi, L; Tremoli, E; Zoja, C1
Basal, S; Caglar, K; Eyileten, T; Ipcioglu, OM; Kaya, A; Korkmaz, A; Oguz, Y; Sonmez, A; Topal, T; Vural, A; Yenicesu, M; Yilmaz, MI1
Davis, P; Exner, M; Kerjaschki, D; Neale, TJ; Ojha, PP; Poczewski, H; Rüger, B; Witztum, JL1
Harris, KP; Hattersley, JM; Moorhead, JF; Ramaswamy, C; Thomas, ME; Varghese, Z; Walls, J; Wheeler, DC; Williams, JD1
Alsina, J; Andrés, E; Castelao, AM; Castiñeiras, MJ; Galcerán, JM; Gilvernet, S; González, MT; Griñó, JM; Roca, M; Serón, D1
Ideura, T; Inui, K; Iwasaki, S; Nemoto, T; Sugenoya, Y; Taira, T; Uda, S; Watanabe, S; Yokota, N; Yoshimura, A1
Fujigaki, Y; Hishida, A; Ikegaya, N; Suzuki, H; Togawa, A; Yonemura, K1
Abbate, M; Cattaneo, D; Corna, D; Remuzzi, G; Rottoli, D; Tomasoni, S; Zanchi, C; Zoja, C1
La Belle, P; Mantel, G1
Delanghe, J; Deslypere, JP; Vermeulen, A1

Reviews

2 review(s) available for simvastatin and Proteinuria

ArticleYear
Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis.
    Scientific reports, 2019, 11-12, Volume: 9, Issue:1

    Topics: Atorvastatin; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Diseases; Lovastatin; Network Meta-Analysis; Pravastatin; Proteinuria; Rosuvastatin Calcium; Simvastatin; Treatment Outcome

2019
[Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:2 Pt 1

    Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Dyslipidemias; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Graft Rejection; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Kidney Failure, Chronic; Liver Transplantation; Middle Aged; Pravastatin; Primary Prevention; Prospective Studies; Proteinuria; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Time Factors

2006

Trials

4 trial(s) available for simvastatin and Proteinuria

ArticleYear
Therapy with statins in patients with refractory rheumatic diseases: a preliminary study.
    Lupus, 2003, Volume: 12, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Atorvastatin; Biomarkers; Blood Sedimentation; C-Reactive Protein; Child; Chloroquine; Dose-Response Relationship, Drug; Granulomatosis with Polyangiitis; Heptanoic Acids; HLA-DR Antigens; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Middle Aged; Proteinuria; Pyrroles; Rheumatic Diseases; Rheumatic Fever; Simvastatin; Treatment Outcome

2003
Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria.
    Kidney international, 1993, Volume: 44, Issue:5

    Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Apolipoprotein B-100; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Double-Blind Method; Female; Humans; Hypercholesterolemia; Inulin; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Placebos; Proteinuria; Simvastatin; Triglycerides

1993
HMGCoA reductase inhibitors lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation.
    Transplantation proceedings, 1993, Volume: 25, Issue:1 Pt 2

    Topics: Adult; Anticholesteremic Agents; Apolipoproteins; Body Mass Index; Body Weight; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunosuppression Therapy; Kidney Transplantation; Lipids; Lipoproteins; Lovastatin; Male; Postoperative Complications; Proteinuria; Simvastatin; Triglycerides

1993
Simvastatin and proteinuria.
    Lancet (London, England), 1991, Apr-06, Volume: 337, Issue:8745

    Topics: Anticholesteremic Agents; Drug Administration Schedule; Drug Evaluation; Humans; Lovastatin; Proteinuria; Simvastatin

1991

Other Studies

15 other study(ies) available for simvastatin and Proteinuria

ArticleYear
Intensive perioperative simvastatin treatment protects from chronic kidney allograft injury.
    American journal of nephrology, 2015, Volume: 41, Issue:4-5

    Topics: Allografts; Animals; Creatinine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Transplantation; Perioperative Care; Proteinuria; Rats; Renal Insufficiency, Chronic; Reperfusion Injury; Simvastatin; Tissue Donors; Transplant Recipients

2015
Simvastatin ameliorates renal lipidosis through the suppression of renal CXCL16 expression in mice with adriamycin-induced nephropathy.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:12

    Topics: Animals; Chemokine CXCL16; Chemokine CXCL6; Cholesterol; Disease Models, Animal; Down-Regulation; Doxorubicin; Endocytosis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Kidney Glomerulus; Lipidoses; Lipoproteins, LDL; Male; Mice, Inbred BALB C; NF-kappa B; Proteinuria; Signal Transduction; Simvastatin

2015
A rare cause of nephrotic syndrome: lipoprotein glomerulopathy.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2009, Volume: 15, Issue:1

    Topics: Adult; Apolipoproteins E; DNA Mutational Analysis; Glomerulonephritis; Hong Kong; Humans; Hypolipidemic Agents; Lipoproteins; Male; Mutation; Nephrosis, Lipoid; Nephrotic Syndrome; Polymerase Chain Reaction; Proteinuria; Simvastatin

2009
Beneficial effect of triple treatment plus immunoglobulin in experimental nephrotic syndrome.
    Pediatric nephrology (Berlin, Germany), 2009, Volume: 24, Issue:6

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Creatinine; Drug Therapy, Combination; Enalapril; Immunoglobulins; Immunologic Factors; Losartan; Male; Nephrotic Syndrome; Proteinuria; Rats; Rats, Wistar; Simvastatin; Time Factors; Treatment Outcome

2009
Gross proteinuria and subacute renal failure after coronary angiography - a case report of cholesterol crystal embolization.
    Wiener klinische Wochenschrift, 2010, Volume: 122, Issue:7-8

    Topics: Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Austria; Benzimidazoles; Biopsy; Biphenyl Compounds; Blood Component Removal; Cholesterol, LDL; Combined Modality Therapy; Coronary Angiography; Coronary Artery Disease; Disease Progression; Embolism, Cholesterol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Malignant; Kidney; Male; Middle Aged; Proteinuria; Simvastatin; Tetrazoles

2010
Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.
    Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:3

    Topics: Acute-Phase Proteins; Animals; Cerebral Arteries; Chemokine CCL2; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; P-Selectin; Proteinuria; Pyrimidines; Rats; Rats, Inbred SHR; RNA, Messenger; Rosuvastatin Calcium; Simvastatin; Sodium Chloride, Dietary; Stroke; Sulfonamides; Transcription, Genetic; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Vasculitis

2005
Effects of simvastatin on oxidative stress in streptozotocin-induced diabetic rats: a role for glomeruli protection.
    Nephron. Experimental nephrology, 2005, Volume: 101, Issue:1

    Topics: Albuminuria; Animals; Antioxidants; Blood Glucose; Catalase; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glutathione Transferase; Hypolipidemic Agents; Kidney Glomerulus; Lipid Peroxidation; Male; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Simvastatin; Superoxide Dismutase; Triglycerides

2005
Simvastatin protection against acute immune-mediated glomerulonephritis in mice.
    Kidney international, 2006, Volume: 69, Issue:3

    Topics: Acute Disease; Animals; Blood Urea Nitrogen; Disease Progression; Dose-Response Relationship, Drug; Female; Glomerulonephritis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Mevalonic Acid; Mice; Mice, Inbred C57BL; Proteinuria; Severity of Illness Index; Simvastatin

2006
Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats.
    The American journal of pathology, 2007, Volume: 170, Issue:4

    Topics: Actins; Animals; Blood Pressure; Blotting, Western; Collagen; Disease Progression; Fibrinogen; Fibrinolysin; Fibrosis; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Kidney; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microscopy, Electron; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Podocytes; Proteinuria; Pyrimidines; Rats; Rats, Inbred SHR; Rosuvastatin Calcium; Simvastatin; Stroke; Sulfonamides

2007
Hyperbaric oxygen treatment augments the efficacy of cilazapril and simvastatin regimens in an experimental nephrotic syndrome model.
    Clinical and experimental nephrology, 2008, Volume: 12, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Cilazapril; Combined Modality Therapy; Disease Models, Animal; Doxorubicin; Glutathione Peroxidase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperbaric Oxygenation; Kidney; Male; Nephrotic Syndrome; Oxidative Stress; Protein Carbonylation; Proteinuria; Rats; Rats, Sprague-Dawley; Simvastatin; Superoxide Dismutase

2008
Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen.
    The Journal of clinical investigation, 1994, Volume: 94, Issue:4

    Topics: Aldehydes; Animals; Anticholesteremic Agents; Antigen-Antibody Complex; Basement Membrane; Cholesterol; Collagen; Disease Models, Animal; Epithelial Cells; Glomerulonephritis; Kidney Glomerulus; Lipid Peroxidation; Lovastatin; Lysine; Male; Malondialdehyde; Probucol; Proteinuria; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Simvastatin

1994
Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
    Journal of the American Society of Nephrology : JASN, 1998, Volume: 9, Issue:11

    Topics: Actins; Animals; Cell Division; Collagen; Creatinine; Extracellular Matrix; Glomerular Mesangium; Glomerulonephritis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Glomerulus; Macrophages; Muscle, Smooth; Platelet-Derived Growth Factor; Proteinuria; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Reference Values; RNA, Messenger; Simvastatin

1998
Potential therapeutic effect of simvastatin on progressive renal failure and nephrotic-range proteinuria caused by renal cholesterol embolism.
    The American journal of the medical sciences, 2001, Volume: 322, Issue:1

    Topics: Anticholesteremic Agents; Creatinine; Disease Progression; Embolism, Cholesterol; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nephrosis; Proteinuria; Simvastatin; Treatment Outcome

2001
Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Kidney international, 2002, Volume: 61, Issue:5

    Topics: Alanine Transaminase; Angiotensin-Converting Enzyme Inhibitors; Animals; Aspartate Aminotransferases; Blood Pressure; Body Weight; CD4-Positive T-Lymphocytes; Chemokine CCL2; Cholesterol; Disease Models, Animal; Drug Therapy, Combination; Eating; Glomerulonephritis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Lisinopril; Male; Proteinuria; Rats; Rats, Sprague-Dawley; RNA, Messenger; Simvastatin; Triglycerides

2002
Proteinuria as complication of simvastatin treatment.
    Lancet (London, England), 1990, Dec-08, Volume: 336, Issue:8728

    Topics: Albuminuria; Anticholesteremic Agents; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Proteinuria; Simvastatin; Transferrin

1990